StageMark
Pittsburgh, Pennsylvania, United States
About StageMark
StageMark develops and markets inflammatory diseases identification and monitoring solutions. The company's product, CB-CAPs, enables user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes. StageMark, Inc. was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2007)
- Website: stagemark.de
- Phone: +1 33 22 - 23 45 98
Industries & Categories
Biotechnology, Medical Device, Software
Canonical: https://fsome.com/organization/stagemark-2252916 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.